Overview

A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs)

Status:
Completed

Trial end date:
2016-10-31

Target enrollment:

Participant gender:

Summary

The purpose of this trial is to investigate the safety and tolerability of perampanel in long- term treatment in the patients with refractory partial epilepsy (uncontrolled with other anti-epileptic drugs) who completed Week 10 of Phase II Study E2007-J081-231 study.

Phase:

Phase 2

Details

Lead Sponsor:

Eisai Co., Ltd.

Treatments:

Anticonvulsants